Norlase

Innovative, ultra-portable, affordable ophthalmic laser devices maximize practice efficiency and improve patient care.

Founded 2014 Denmark

Denmark 75 employees Growth Total: $56.45M Manufacturing, Medical Devices

General Information

Company Name Norlase

Founded Year 2014

Location

Denmark

Founders / Decision Makers

Employees 75

Industries Manufacturing, Medical Devices

Funding Stage Growth

Business Model B2B, D2C, E Commerce

Revenue Model Product Sales, Service Fee, Leasing/Rental

Social

BounceWatch is an independent company data service, not affiliated with Norlase. To contact Norlase, visit norlase.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Norlase compare?

A PDF of Norlase and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Norlase soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Sep 14, 2026

Norlase is participating as an exhibitor at The European Society of Cataract and Refractive Surgeons (ESCRS), located at Booth F.116, with the event concluding on 2026-09-14.

New Partnership Sep 11, 2026

Norlase is likely collaborating with Technomix for the introduction of the LYNX laser in Mexico, as indicated by post hashtags.

Market Expansion Sep 10, 2026

Norlase is establishing a direct commercial presence in the UK.

Get alerts when Norlase shows new signals

AI Insight

Bounce Watch AI

1 month ago

Norlase is exhibiting strong growth momentum driven by recent product innovation, notably the launch of LYNX, a portable pattern LIO. This is coupled with significant strategic expansion into underserved global regions like Ukraine and Sub-Saharan Africa, further supported by a new distribution partnership and a major customer win. These developments collectively underscore Norlase's successful execution in deploying capital to expand market reach and enhance ophthalmic care with innovative, accessible laser devices.

Signal Types

Product Launch Market Expansion Partnership Customer Acquisition

Strategic Labels

Product Innovation Global Market Penetration Distribution Growth

Next Move: Market Expansion

Impact: 9/10

Ideal For: Growth Equity VCs — MedTech, Global Expansion Focus

About Norlase

Norlase, founded in 2014 and headquartered in Denmark, is disrupting the ophthalmic laser market with its innovative, portable, and affordable devices aimed at maximizing practice efficiency and enhancing patient care. Their slogan, "Innovative, ultra-portable, affordable ophthalmic laser devices maximize practice efficiency and improve patient care," encapsulates their mission.

With a focus on simplicity and impact, Norlase collaborates with ophthalmologists and industry leaders to pioneer advances in laser technology and medical device development. Their product line, including ECHO, LEAF, and LION, represents breakthroughs in portable and wireless ophthalmic care, addressing existing technological challenges and optimizing clinical workflow.

Having secured a €20.00M debt financing investment from the European Investment Bank on 01 February 2025, Norlase is well-positioned to expand its impact and continue leading in the medical devices industry.

Business keywords: Ophthalmic Laser Devices, Portable Laser Technology, Medical Device Innovation, Ophthalmology Solutions, Vision Care Technology, Retina Treatment, Glaucoma Treatment, Pattern Scanning Lasers, Wireless Ophthalmoscope, Subthreshold Laser Treatment, Slit-Lamp Mounted Lasers, Battery-Powered Lasers, Voice Control Interface, Healthcare Efficiency, Customer Care in Ophthalmology

Services & Products

Design and Manufacturing of Ophthalmic Laser Systems

Development of Pattern Scanning Lasers

Innovation in Laser Photocoagulation Solutions

Target Customers

Ophthalmologists Optometrists Eye Clinics Healthcare Facilities Specializing in Eye Care

Funding Rounds & Investors (13)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Debt Financing	€20.00M	1	European Investment Bank	01 Feb 2025
Growth Equity VC	$11.00M	1	West Hill Capital	01 Jun 2023
Series B	£10.60M	-		01 Oct 2021
Secondary Market	Undisclosed	-		01 Jan 2021
Early VC	$4.10M	-		01 Sep 2020
Early VC	$6.00M	-		01 Mar 2019
Grant	$2.80M	-		01 Nov 2018
Grant	€300.00K	-		01 Feb 2018
Grant	€1.40M	1	Horizon 2020 FET (Future and Emerging Technologies)	01 Oct 2016
Grant	€50.00K	1	European Innovation Council	01 Jun 2016

View All 13 Funding Rounds

Norlase Alternatives & Competitors

View All Alternatives

Norlase vs

HOSPITECH MANUFACTURING SERVICES SDN BHD Malaysia

A Malaysia medical device manufacturer and distributor exporting worldwide.

11 employees

Manufacturing, Medical Devices

Compare Norlase vs HOSPITECH MANUFACTURING SERVICES SDN BHD

Norlase vs

Surgmed Group Canada

Three Companies, One Mission. We are dedicated to offering world class medical devices and customer...

44 employees

Health Care, Manufacturing

Compare Norlase vs Surgmed Group

Norlase vs

Katsan Medical Devices Turkey

Professional Tools for Professional Hands

38 employees

Manufacturing, Medical Devices

View all alternatives

FAQ About Norlase

Innovative, ultra-portable, affordable ophthalmic laser devices maximize practice efficiency and improve patient care.

Norlase was founded in 2014.

Norlase is headquartered in Denmark.

Norlase operates in Manufacturing and Medical Devices. Its work centres on Ophthalmic Laser Devices, Portable Laser Technology, Medical Device Innovation and Ophthalmology Solutions. Its customers include Ophthalmologists, Optometrists and Eye Clinics.

Norlase has a B2B, D2C and E Commerce business model. Its revenue comes from Product Sales, Service Fee and Leasing/Rental.

Norlase has approximately 75 employees.

Norlase has completed 13 funding rounds, raising a total of $56.45M. The latest funding stage is Growth.

Norlase offers: Design and Manufacturing of Ophthalmic Laser Systems, Development of Pattern Scanning Lasers, Innovation in Laser Photocoagulation Solutions.

Top alternatives and competitors to Norlase include HOSPITECH MANUFACTURING SERVICES SDN BHD, Surgmed Group, Katsan Medical Devices, Betatech Medical, enmodes GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Norlase and HOSPITECH MANUFACTURING SERVICES SDN BHD are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Norlase, https://bouncewatch.com/company/norlase, updated 15 September 2026. When citing, please name BounceWatch and link this page.

Norlase

General Information

Discover More

What changed at Norlase recently?

AI Insight

About Norlase

Services & Products

Target Customers

Funding Rounds & Investors (13)

Norlase Alternatives & Competitors

FAQ About Norlase